Terms: = Liver cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Prognosis
16 results:
1. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.
Pallerla SR; Hoan NX; Rachakonda S; Meyer CG; Van Tong H; Toan NL; Linh LTK; Giang DP; Kremsner PG; Bang MH; Song LH; Velavan TP
BMC Med Genomics; 2022 Nov; 15(1):235. PubMed ID: 36345011
[TBL] [Abstract] [Full Text] [Related]
2. Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway.
Xie H; Jing R; Liao X; Chen H; Xie X; Dai H; Pan L
Hereditas; 2022 Jul; 159(1):29. PubMed ID: 35836300
[TBL] [Abstract] [Full Text] [Related]
3. Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
Sun L; Xi S; Zhou Z; Zhang F; Hu P; Cui Y; Wu S; Wang Y; Wu S; Wang Y; Du Y; Zheng J; Yang H; Chen M; Yan Q; Yu D; Shi C; Zhang Y; Xie D; Guan XY; Li Y
Oncogene; 2022 Jan; 41(5):732-744. PubMed ID: 34845378
[TBL] [Abstract] [Full Text] [Related]
4. Gd-EOB-DTPA-enhanced magnetic resonance imaging may help identify patients with hepatocellular carcinoma eligible for treatment targeted at raf1.
Mo Z; Ding H; Zhou X; Zeng Z; Long L
Abdom Radiol (NY); 2022 Jan; 47(1):209-220. PubMed ID: 34738148
[TBL] [Abstract] [Full Text] [Related]
5. CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway.
Zhao D; Yang Z; Chen C; Zhang Z; Yu Y; Li Z
FEBS Open Bio; 2021 Nov; 11(11):3115-3125. PubMed ID: 34555268
[TBL] [Abstract] [Full Text] [Related]
6. The crosstalk network of XIST/miR-424-5p/OGT mediates raf1 glycosylation and participates in the progression of liver cancer.
Ning D; Chen J; Du P; Liu Q; Cheng Q; Li X; Zhang B; Chen X; Jiang L
Liver Int; 2021 Aug; 41(8):1933-1944. PubMed ID: 33909326
[TBL] [Abstract] [Full Text] [Related]
7. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
8. Downregulation of raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines.
Kim JS; Choi GH; Jung Y; Kim KM; Jang SJ; Yu ES; Lee HC
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1487-1501. PubMed ID: 29858683
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
[TBL] [Abstract] [Full Text] [Related]
10. Demethylation-Induced Overexpression of Shc3 Drives c-raf-Independent Activation of MEK/ERK in HCC.
Liu Y; Zhang X; Yang B; Zhuang H; Guo H; Wei W; Li Y; Chen R; Li Y; Zhang N
Cancer Res; 2018 May; 78(9):2219-2232. PubMed ID: 29330146
[TBL] [Abstract] [Full Text] [Related]
11. miR‑378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c‑Raf.
Fu H; Zhang J; Pan T; Ai S; Tang L; Wang F
Mol Med Rep; 2018 Mar; 17(3):4581-4588. PubMed ID: 29328399
[TBL] [Abstract] [Full Text] [Related]
12. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.
Wang X; Zhang W; Tang J; Huang R; Li J; Xu D; Xie Y; Jiang R; Deng L; Zhang X; Chai Y; Qin X; Sun B
Cell Death Dis; 2016 Mar; 7(3):e2130. PubMed ID: 26938303
[TBL] [Abstract] [Full Text] [Related]
13. Expression of Raf Kinase Inhibitor Protein (RKIP) is a predictor of uveal melanoma metastasis.
Caltabiano R; Puzzo L; Barresi V; Cardile V; Loreto C; Ragusa M; Russo A; Reibaldi M; Longo A
Histol Histopathol; 2014 Oct; 29(10):1325-34. PubMed ID: 24763848
[TBL] [Abstract] [Full Text] [Related]
14. Reduced raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract] [Full Text] [Related]
15. Expression and prognostic role of pan-Ras, raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma.
Chen L; Shi Y; Jiang CY; Wei LX; Wang YL; Dai GH
Eur J Surg Oncol; 2011 Jun; 37(6):513-20. PubMed ID: 21324414
[TBL] [Abstract] [Full Text] [Related]
16. [Expressions of raf-1 kinase, phosphorylated mitogen extracellular kinase 1, and phosphorylated extracellular signal-regulated protein kinase 1/2 in hepatocellular carcinoma and their relationship with prognosis].
Chen L; Shi Y; Jiang CY; Sun Q; Dai GH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):424-8. PubMed ID: 20868603
[TBL] [Abstract] [Full Text] [Related]
